Stay updated on Clinical Trial: AZD6094 + Docetaxel in MET+ Gastric Cancer
Sign up to get notified when there's something new on the Clinical Trial: AZD6094 + Docetaxel in MET+ Gastric Cancer page.

Latest updates to the Clinical Trial: AZD6094 + Docetaxel in MET+ Gastric Cancer page
- Check5 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedNo substantive changes are visible; the study details and eligibility criteria appear unchanged. Actionable items and sections remain the same across screenshots.SummaryDifference0.1%

- Check33 days agoChange DetectedRevision: v3.5.0 has been applied, replacing the previous v3.4.3.SummaryDifference0.1%

- Check48 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check69 days agoChange DetectedThe page now shows a new revision tag v3.4.2 and removes the previous revision v3.4.1; core study details, eligibility criteria, and results remain unchanged.SummaryDifference0.1%

- Check77 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1. There are no visible changes to study details content or page layout.SummaryDifference0.1%

Stay in the know with updates to Clinical Trial: AZD6094 + Docetaxel in MET+ Gastric Cancer
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: AZD6094 + Docetaxel in MET+ Gastric Cancer page.